SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-008461
Filing Date
2020-05-27
Accepted
2020-05-27 16:18:04
Documents
82
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tlgt-20200331.htm   iXBRL 10-Q 1640061
2 EX-31.1 tlgtq12020ex311.htm EX-31.1 12171
3 EX-31.2 tlgtq12020ex312.htm EX-31.2 12462
4 EX-32.1 tlgtq12020ex321.htm EX-32.1 6369
5 EX-32.2 tlgtq12020ex322.htm EX-32.2 7000
  Complete submission text file 0001628280-20-008461.txt   9105792

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlgt-20200331.xsd EX-101.SCH 55968
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tlgt-20200331_cal.xml EX-101.CAL 106569
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tlgt-20200331_def.xml EX-101.DEF 372018
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlgt-20200331_lab.xml EX-101.LAB 695540
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlgt-20200331_pre.xml EX-101.PRE 523148
60 EXTRACTED XBRL INSTANCE DOCUMENT tlgt-20200331_htm.xml XML 1815740
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 6096971441
Teligent, Inc. (Filer) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-08568 | Film No.: 20915441
SIC: 2834 Pharmaceutical Preparations